Geode Capital Management LLC bought a new position in shares of TruBridge, Inc. (NASDAQ:TBRG – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 145,965 shares of the company’s stock, valued at approximately $1,747,000. Geode Capital Management LLC owned approximately 0.98% of TruBridge as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Charles Schwab Investment Management Inc. bought a new stake in TruBridge during the third quarter worth $875,000. GSA Capital Partners LLP bought a new stake in shares of TruBridge during the 3rd quarter worth $389,000. BNP Paribas Financial Markets purchased a new position in shares of TruBridge in the 3rd quarter worth about $161,000. State Street Corp bought a new position in TruBridge during the third quarter valued at about $829,000. Finally, GAMMA Investing LLC purchased a new stake in TruBridge during the third quarter worth about $26,000. Hedge funds and other institutional investors own 88.64% of the company’s stock.
Insider Activity
In other news, Director Mark V. Anquillare acquired 2,500 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was bought at an average cost of $16.81 per share, for a total transaction of $42,025.00. Following the completion of the transaction, the director now owns 17,178 shares of the company’s stock, valued at $288,762.18. The trade was a 17.03 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 3.60% of the stock is owned by company insiders.
TruBridge Stock Up 3.9 %
Analyst Ratings Changes
A number of research firms have recently weighed in on TBRG. Barclays increased their target price on shares of TruBridge from $10.00 to $14.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. Cantor Fitzgerald reissued an “overweight” rating and issued a $13.00 target price on shares of TruBridge in a research report on Friday, October 4th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $14.00 price target on shares of TruBridge in a research report on Tuesday, September 17th. Finally, Stephens lifted their price objective on TruBridge from $13.00 to $17.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 20th.
Get Our Latest Stock Analysis on TruBridge
TruBridge Profile
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Read More
- Five stocks we like better than TruBridge
- How to Calculate Inflation Rate
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What Are Dividend Contenders? Investing in Dividend Contenders
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Options Trading – Understanding Strike Price
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.